<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02928497</url>
  </required_header>
  <id_info>
    <org_study_id>S2317</org_study_id>
    <nct_id>NCT02928497</nct_id>
  </id_info>
  <brief_title>Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation</brief_title>
  <acronym>ASAP-TOO</acronym>
  <official_title>Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left
      Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for
      subjects with non-valvular atrial fibrillation who are deemed not to be eligible for
      anti-coagulation therapy to reduce the risk of stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ASAP-TOO study is a prospective, randomized, multi-center, global investigation to
      establish the safety and effectiveness of the WATCHMAN Device for subjects with non-valvular
      atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the
      risk of stroke.

      Subjects will be randomized in a ratio of 2 Device to 1 Control to receive the WATCHMAN LAA
      closure device (Device) or the control treatment of single antiplatelet medication or no
      medication at the discretion of the study physician (Control). All randomized subjects will
      follow the protocol required tests and assessments at each scheduled follow-up visit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary 7-Day Device/Procedural Safety Endpoint</measure>
    <time_frame>7 days</time_frame>
    <description>The primary safety endpoint is the 7-day combined rate of death, ischemic stroke, systemic embolism and complications requiring major cardiovascular or endovascular intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Efficacy Endpoint - time to first event of ischemic stroke or systemic embolism.</measure>
    <time_frame>5 years</time_frame>
    <description>The primary efficacy endpoint is the comparison of time to first event of ischemic stroke and systemic embolism.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint - Composite of All Stroke and Cardiovascular or Unknown Death</measure>
    <time_frame>5 years</time_frame>
    <description>The occurrence of stroke (including ischemic and/or hemorrhagic), cardiovascular death (cardiovascular and/or unexplained cause) and systemic embolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoint - Major Bleeding</measure>
    <time_frame>5 years</time_frame>
    <description>The occurrence of major bleeding (defined as a BARC Type 3 or 5 event)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">888</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>WATCHMAN (Device)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>WATCHMAN LAAC Device implant including modified post-implant drug regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single antiplatelet therapy (Control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single antiplatelet therapy or no therapy at the discretion of the study physician for the duration of the trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WATCHMAN LAAC Implant</intervention_name>
    <description>WATCHMAN LAAC Implant</description>
    <arm_group_label>WATCHMAN (Device)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Single Antiplatelet Therapy of No Therapy</intervention_name>
    <description>Single Antiplatelet Therapy or No Therapy at the discretion of the study physician.</description>
    <arm_group_label>Single antiplatelet therapy (Control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is of legal age to participate in the study per the laws of their
             respective geography.

          -  The subject has documented paroxysmal, persistent, permanent or long-term/longstanding
             persistent non-valvular atrial fibrillation (i.e., the subject has not been diagnosed
             with rheumatic mitral valvular heart disease).

          -  The subject has a calculated CHA2DS2-VASc score of 2 or greater.

          -  The subject is deemed by two study physicians to be unsuitable for oral
             anticoagulation.

          -  The subject is deemed by a study physician to be suitable for the defined protocol
             pharmacologic regimen of aspirin and clopidogrel therapy following WATCHMAN Closure
             Device implant.

          -  The subject or legal representative is able to understand and willing to provide
             written informed consent to participate in the trial.

          -  The subject is able and willing to return for required follow-up visits and
             examinations.

        Exclusion Criteria:

          -  The subject is unable or unwilling to return for required follow-up visits and
             examinations.

          -  The subject had or is planning to have any invasive cardiac procedure within 30 days
             prior to randomization (e.g., cardioversion, ablation).

          -  The subject is planning to have any cardiac or non-cardiac invasive or surgical
             procedure that would necessitate stopping or modifying the protocol required
             medication regimen within 90 days after the WATCHMAN Closure Device implant (e.g.,
             cardioversion, ablation, cataract surgery).

          -  The subject had a prior stroke (of any cause) or TIA within the 30 days prior to
             randomization.

          -  The subject had a prior BARC type 3 or 4 bleeding event within the 14 days prior to
             randomization. Lack of resolution of related clinical sequelae, or planned and pending
             interventions to resolve bleeding/bleeding source, are a further exclusion regardless
             of timing of the bleeding event.

          -  The subject has a history of atrial septal repair or has an ASD/PFO device.

          -  The subject has an implanted mechanical valve prosthesis in any position.

          -  The subject suffers from New York Heart Association Class IV Congestive Heart Failure.

          -  The subject has LVEF &lt; 30%.

          -  The subject is of childbearing potential and is, or plans to become pregnant during
             the time of the study (method of assessment upon study physician's discretion).

          -  The subject is currently enrolled in another investigational study or registry that
             would directly interfere with the current study, except when the subject is
             participating in a mandatory governmental registry, or a purely observational registry
             with no associated treatments. Each instance should be brought to the attention of the
             sponsor to determine eligibility.

          -  The subject has a life expectancy of less than two years.

          -  The subject has a known or suspected hypercoagulable state.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacqueline Saw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vancouver General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vivek Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurice Buchbinder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Williams</last_name>
    <phone>1-800-CARDIAC</phone>
    <email>Jennifer.Williams2@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin Hynes</last_name>
    <phone>1-800-CARDIAC</phone>
    <email>Erin.Hynes@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grandview Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Thorington</last_name>
      <phone>205-971-7578</phone>
      <email>sthorington@alcardio.com</email>
    </contact>
    <investigator>
      <last_name>Jose Osorio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner University Medical Center Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Schohn</last_name>
      <phone>602-839-3546</phone>
      <email>jschohn@email.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Ashish Pershad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arizona Arrhythmia Research Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Raymond</last_name>
      <phone>602-456-2342</phone>
      <email>sraymond@azheartrhythm.com</email>
    </contact>
    <investigator>
      <last_name>Vijendra Swarup</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of Northeast Arkansas, P.A.</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kayla Rubino</last_name>
      <phone>870-935-6729</phone>
      <email>krubino@stbheart.com</email>
    </contact>
    <investigator>
      <last_name>Devi Nair</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars - Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mane Arabyan</last_name>
      <phone>310-248-8515</phone>
      <email>mane.arabyan@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Saibal Kar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharpe Chula Vista Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Wilkerson</last_name>
      <phone>858-625-4488</phone>
      <email>dwilkerson@fcvmed.org</email>
    </contact>
    <investigator>
      <last_name>Maurice Buchbinder</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John's Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Ducharme</last_name>
      <phone>310-829-7678</phone>
      <email>crystal.ducharme@providence.org</email>
    </contact>
    <investigator>
      <last_name>Shephal Doshi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shine Kim</last_name>
      <phone>202-877-7066</phone>
      <email>shine.y.kim@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Manish Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Medical Center</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adrienne Haines-Adams</last_name>
      <phone>863-688-5842</phone>
      <email>ahaines-adams@watsonclinic.com</email>
    </contact>
    <investigator>
      <last_name>Neal Kavesh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patty Knap</last_name>
      <phone>850-431-5024</phone>
      <email>Patty.Knap@tmh.org</email>
    </contact>
    <investigator>
      <last_name>Farhat Khairallah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Smith</last_name>
      <phone>404-686-7992</phone>
      <email>pfsmith@emory.edu</email>
    </contact>
    <investigator>
      <last_name>David Delurgio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Daugherty</last_name>
      <phone>404-605-2301</phone>
      <email>julia.daugherty@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Sandeep Goyal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Carswell</last_name>
      <phone>312-926-7554</phone>
      <email>amy.carswell@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Bradley Knight</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Keller</last_name>
      <phone>847-570-3861</phone>
      <email>jkeller@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Ted Feldman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Edward Hospital</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60540</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherri McCoy</last_name>
      <phone>630-527-2730</phone>
      <email>sherri.mccoy@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Moeen Saleem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Health Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Schneider</last_name>
      <phone>859-260-6066</phone>
      <email>kschneid@bhsi.com</email>
    </contact>
    <investigator>
      <last_name>Gery Tomassoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Campbell</last_name>
      <phone>443-278-9170</phone>
      <email>rachel.e.campbell@medstar.net</email>
    </contact>
    <investigator>
      <last_name>John Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Alexander</last_name>
      <phone>313-916-9598</phone>
      <email>salexan4@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Claudio Schuger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veleda Sterling</last_name>
      <phone>248-898-8141</phone>
      <email>veleda.sterling@beaumont.org</email>
    </contact>
    <investigator>
      <last_name>Steven Almany</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Foundation</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Desirae Howe-Clayton</last_name>
      <phone>507-538-3429</phone>
      <email>howe.desirae@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>David Holmes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HealthEast St. Joseph's Hospital</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Jorgenson</last_name>
      <phone>651-232-3274</phone>
      <email>bjorgenson@healtheast.org</email>
    </contact>
    <investigator>
      <last_name>Stuart Adler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Mississippi Medical Center</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin Eads</last_name>
      <phone>662-377-7572</phone>
      <email>keads@nmhs.net</email>
    </contact>
    <investigator>
      <last_name>James Stone Jr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margie Miller</last_name>
      <phone>816-932-6248</phone>
      <email>m2miller@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Kenneth Huber</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Cornelius</last_name>
      <phone>603-663-6094</phone>
      <email>elizabeth.cornelius@cmc-nh.org</email>
    </contact>
    <investigator>
      <last_name>Jamie Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine McGowan</last_name>
      <phone>516-562-2345</phone>
      <email>kmcgowan@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Apoor Patel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lance Glickman</last_name>
      <phone>212-824-8930</phone>
      <email>lance.glickman@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Srinivas Dukkipati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rochester General Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Noll</last_name>
      <phone>585-922-3536</phone>
      <email>patricia.noll@rochesterregional.org</email>
    </contact>
    <investigator>
      <last_name>Jeremiah Depta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie Dellinger</last_name>
      <phone>704-355-4794</phone>
      <email>Connie.Dellinger@carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>J. Holshouser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Lake</last_name>
      <phone>717-851-5153</phone>
      <email>slake@wellspan.org</email>
    </contact>
    <investigator>
      <last_name>James Harvey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Health</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Embry</last_name>
      <email>leslie.embry@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Robert Pickett</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Carroll</last_name>
      <phone>615-936-1293</phone>
      <email>amanda.carroll@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Piana</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Headley</last_name>
      <phone>214-820-7108</phone>
      <email>cathy.headley@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>James Choi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Houston Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawnee Carpenter</last_name>
      <phone>713-486-1625</phone>
      <email>shawnee.carpenter@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Saumya Sharma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Medical Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Bailes</last_name>
      <phone>434-982-1058</phone>
      <email>lgs2m@hscmail.mcc.virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Rohit Malhotra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Zulick</last_name>
      <phone>757-388-1695</phone>
      <email>mrzulick@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Paul Mahoney</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Behr</last_name>
      <phone>414-649-6853</phone>
      <email>gina.behr@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Jasbir Sra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Onze Lieve Vrouw Ziekenhuis</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy De Knijf</last_name>
      <phone>3253724449</phone>
      <email>cardio.studie.aalst@olvz-aalst.be</email>
    </contact>
    <investigator>
      <last_name>Tom De Potter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asuncion Conde Y Bolado</last_name>
      <email>Asuncion.CondeYBolado@chu-charleroi.be</email>
    </contact>
    <investigator>
      <last_name>Adel Aminian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hôpital Universitaire Sart Tilman</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Francoise Dive</last_name>
      <phone>3343667854</phone>
      <email>Af.dive@chu.ulg.ac.be</email>
    </contact>
    <investigator>
      <last_name>Patrizio Lancellotti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skejby Sygehus</name>
      <address>
        <city>Aarhus N</city>
        <zip>DK-8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorte Frydendahl Bjerre</last_name>
      <phone>4540141636</phone>
      <email>dortemoe@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Jens Erik Nielsen Kudsk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Line Kristensen</last_name>
      <phone>4535458993</phone>
      <email>line.marboe.kristensen@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Lars Soendergaard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2016</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-valvular atrial fibrillation</keyword>
  <keyword>Left atrial appendage</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

